NR1I2 and hepatocellular carcinoma: PXR is the regulatory hub for the body’s metabolism and clearance of exogenous drugs and toxic agents, and it can also participate in the regulation of hepatocellular carcinoma (HCC) and other malignant tumor cells’ resistance to anti-tumor drugs [2].